Bonus Biogroup Ltd. · NASDAQ:BONS

Bonus Biogroup Ltd. financial statements

Bonus Biogroup Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in ILS

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000000000
Cost of revenue2.76M2.79M2.76M3.37M4.10M1.61M1.34M1.14M
Gross profit-2.76M-2.79M-2.76M-3.37M-4.10M-1.61M-1.34M-1.14M
Research and development11.2M17.6M18.6M21.3M19.5M10.4M11.1M10.8M10.9M8.56M
Selling, general and administrative2.49M10.2M11.2M5.46M31.3M2.80M2.39M7.63M9.24M9.06M
Operating income-22.6M-27.8M-28.3M-37.0M-64.7M-19.4M-20.9M-18.4M-20.1M-16.0M
Depreciation and amortization2.76M2.79M2.76M2.66M1.48M1.07M1.08M197.0K163.0K410.0K
EBITDA-19.9M-25.0M-25.6M-34.4M-63.3M-18.4M-19.8M-18.3M-20.0M-15.6M
Interest expense703.0K797.0K879.0K891.0K569.0K473.0K460.0K364.0K67.0K83.0K
Income before tax-24.5M-27.8M-28.5M-38.7M-90.1M-22.0M-22.2M-18.7M-20.2M-16.0M
Income tax-15.0K-195.0K79.0K0119.0K
Net income-24.5M-27.8M-28.5M-38.7M-90.1M-22.0M-22.2M-18.7M-20.2M-16.0M
Earnings per share, basic-0.04-0.02-0.02-0.06-0.16-0.02-0.03-0.02-0.02-0.07

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents228.0K6.86M12.9M53.6M79.5M16.1M105.0K8.64M2.73M1.40M
Receivables624.0K92.0K250.0K505.0K1.16M410.0K102.0K424.0K1.88M642.0K
Current assets1.75M7.19M26.4M54.4M81.0M16.7M308.0K9.09M4.65M2.08M
Property, plant and equipment19.8M15.0M5.73M6.58M973.0K829.0K717.0K
Goodwill39.0K
Total assets15.4M23.4M44.9M74.6M104.3M51.4M6.99M10.2M5.58M2.90M
Accounts payable1.84M1.01M1.41M1.95M3.99M1.56M1.48M1.22M1.05M1.35M
Current liabilities14.0M7.92M5.91M7.62M8.77M16.4M15.5M12.4M12.0M10.3M
Total debt8.90M10.2M11.2M12.0M12.3M5.15M5.88M
Total liabilities21.1M16.4M15.6M18.2M19.9M20.8M20.7M13.3M12.0M10.3M
Shareholders' equity-5.66M6.96M29.3M56.4M84.4M30.7M-13.7M-3.18M-6.38M-7.36M
Shares outstanding669.7M1.17B1.17B621.1M579.1M1.03B841.5M811.7M809.6M233.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-14.9M-21.4M-26.4M-28.8M-39.8M-15.7M-13.1M-13.4M-11.8M-9.63M
Capital spending-12.0K-342.0K-824.0K-6.39M-5.81M-254.0K-187.0K-341.0K-269.0K-191.0K
Free cash flow-14.9M-21.7M-27.2M-35.2M-45.6M-16.0M-13.3M-13.8M-12.1M-9.82M
Cash from investing-12.0K12.7M-14.3M-6.29M-6.18M-254.0K-187.0K-341.0K-269.0K-180.0K
Cash from financing8.41M2.55M-1.16M2.13M113.4M31.9M4.92M19.6M13.4M6.79M
Share buybacks13.4M6.79M
Change in cash-6.63M-6.08M-40.7M-25.9M63.5M16.0M-8.54M5.92M1.32M-3.01M